Reading Time: 4 minutesThis is blog number 5 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green text correspond
Reading Time: 6 minutesThis is blog number 4 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green text correspond
Reading Time: 4 minutesThis is blog number 3 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green text correspond
Reading Time: 5 minutesThis is blog number two in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green text correspond
Reading Time: 5 minutesWelcome to our ‘Symposium Blogathon’ – a series of blogs counting down to the start of the 32nd International Symposium on ALS/MND’. Every weekday throughout
Reading Time: 4 minutesHi everyone! Ever wondered who is behind some of the research blogs that you read? It’s the research information team. It is not just the
Reading Time: 4 minutesThis week marks global Peer Review Week and we are joining the international science community in celebrating the role that peer reviewers play in the
Reading Time: 4 minutesTranslational Research is the term used to describe studies that are the bridge between fundamental laboratory-based research and the testing of potential therapies (often by
Reading Time: 5 minutes“The search for new drugs to help MND patients is a long and challenging one, but it is one where we are beginning to see
Reading Time: 7 minutesGlobal biotechnology company Biogen has announced plans to make tofersen, a potential treatment for people whose MND is believed to be driven by mutations in